FDA Set to Review Peptide Access for Compounding Pharmacies Drug Topics Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals Any sports medicine rejuvenation clinics in HCM that offer BPC 157 TB 500 treatment? The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Revive Peptides, Lab Peptides for Muscle Research & Growth REVIVE PEPTIDES